swiTching From etAnercept to iNfliximab in the treatment of moderate to severe psoriasis; a multi-center, open label trial evaluatinG the efficacy, tOlerance and safety
Phase of Trial: Phase IV
Latest Information Update: 18 Apr 2017
At a glance
- Drugs Infliximab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms TANGO
- Sponsors Merck Sharp & Dohme; Schering-Plough
- 25 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Oct 2009 New trial record.